Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antithrombotic therapy in type 2 diabetic patients: higher-dose aspirin vs low-dose aspirin plus COX-2 inhibitor
2007-003376-20Phase 3Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin and etoricoxib in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Policlinico Gemelli. Primary endpoints: Platelet aggregation reduction and TXA2 level reduction. Started Jan 2008; status: terminated.
02
Drugs
aspirinetoricoxib
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-003376-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003376-20.